Dermira (DERM) Misses Q4 EPS by 13c

Dermira (NASDAQ: DERM) reported Q4 EPS of ($0.60), $0.13 worse than the analyst estimate of ($0.47). Revenue for the quarter came in at $16 million versus the consensus estimate of $16.57 million.

For earnings history and earnings-related data on Dermira (DERM) click here.

You May Also Be Interested In

• Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
• Needham on Barnes & Noble Education (BNED): 'we remain buyers on the weakness'
• Core & Main, Inc (CNM) Tops Q3 EPS by 2c ; Offers Guidance